• Using Our Forums

  Generative AI-derived drug for treating IPF in Phase 2 trials

  Posted by Stewart on December 14, 2023 at 10:56 pm

  Fascinating and hopeful..

  https://www.genengnews.com/topics/artificial-intelligence/insilicos-ai-candidate-for-ipf-doses-first-patient-in-phase-ii/

  

  genengnews.com

  Insilico's AI Candidate for IPF Doses First Patient in Phase II

  Insilico Medicine has dosed the first patient in a Phase II trial of its lead pipeline candidate INS018_055, an idiopathic pulmonary fibrosis (IPF) treatment that was discovered and designed using generative artificial intelligence (AI).

  Stewart replied 10 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply